Everolimus Tablet — FDA Drug Shortage

To Be Discontinued — Par Health, USA LLC

The FDA lists a drug shortage record for Everolimus Tablet (tablet) from Par Health, USA LLC with status To Be Discontinued. The shortage was first posted on Oct 14, 2026.

Shortage details

Status
To Be Discontinued
Company
Par Health, USA LLC
Package NDC
49884-158-02
Dosage Form
Tablet
Presentation
Everolimus, Tablet, .25 mg (NDC 49884-158-02)
Initial Posting
Oct 14, 2026

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.